Effects of (1R,9S)-β-hydrastine on L-DOPA-induced cytotoxicity in PC12 cells

European Journal of Pharmacology

Volumn 488, Issue 1-3, 2004, Pages 71-77

  Yin, Shou Yu ^a,b   Lee, Jae Joon ^a   Kim, Yu Mi ^a   Jin, Chun Mei ^a   Yang, Yoo Jung ^a   Kang, Min Hee ^a   Kai, Masaaki ^c   Lee, Myung Koo ^a  

^a Chungbuk National University   (South Korea)

^b YANBIAN UNIVERSITY   (China)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

(1R,9S) Hydrastine; Apoptosis; Cytotoxicity; L DOPA (L 3,4 dihydroxyphenylalanine); PC12 cell

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; HYDRASTINE; LEVODOPA; OXYGEN RADICAL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; NICK END LABELING; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCYSTEINE; ALKALOIDS; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BENZYLISOQUINOLINES; CELL DEATH; CELL SURVIVAL; DNA FRAGMENTATION; DOPAMINE AGENTS; FLOW CYTOMETRY; FREE RADICAL SCAVENGERS; ISOMERISM; LEVODOPA; PC12 CELLS; RATS;

EID: 1642303043     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.02.021     Document Type: Article

References (30)

1. Basma A.N., Morris E.J., Nicklas W.J., Geller H.M. L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem. 64:1995;825-832.
2. Boyce S., Rupniak N.M., Steventon M.J., Iversen S.D. Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys. Clin. Neuropharmacol. 13:1990;448-458.
3. Desole M.S., Sciola L., Delogu M.R., Siricana R., Migheli R. Manganese and 1-methyl-4-(2′-ethylpheyl)-1,2,3,6-tetrahydropyridine induce apoptosis in PC12 cells. Neurosci. 209:1996;193-196.
4. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 73:1976;2424-2428.
5. Hornykiewicz O. The mechanisms of action of L-DOPA in Parkinson's disease. Life Sci. 15:1994;1249-1259.
6. Huang J.H., Johnston G.A.R. (+)-Hydrastine, a potent competitive antagonist at mammalian GABA receptors. Br. J. Pharmacol. 99:1990;727-730.
7. +)-induced cell death in PC12 cells: inhibitory effects of several drugs. Neurochem. Int. 25:1994;419-424.
8. Itoh K., Weis S., Mehraein P., Muller-Hocker J. Defects in cytochrome c oxidase in the substantia nigra of Parkinson's disease: an immunohistochemical and morphometric study. Mov. Disord. 12:1997;9-16.
9. Kim S.H., Shin J.S., Lee J.J., Yin S.Y., Kai M., Lee M.K. Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med. 67:2001;609-613.
10. Kotake Y., Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Benzyl-1,2,3,4- tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian brain. J. Neurochem. 65:1995;2633-2638.
11. Lee M.K., Zhang Y.H., Shin J.S., Lee S.S. Inhibition of tyrosine hydroxylase by hydrastine. Med. Sci. Res. 25:1997;619-620.
12. Lee J.J., Kim Y.M., Sin S.Y., Park H.D., Kang M.H., Hong J.T., Lee M.K. Aggravation of L-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells. Biochem. Pharmacol. 66:2003;1787-1795.
13. Marsden C.D. Parkinson's disease. J. Neurol. Neruosurg. Psychiatry. 57:1994;672-681.
14. Maruyama W., Abe T., Tohgi H., Dostert P., Naoi M. A dopaminergic neurotoxin, (R)-N-methylsalsolinol increases in parkinsonian cerebrospinal fluid. Ann. Neurol. 40:1996;119-122.
15. McNaught K.St.P., Thull U., Carrupt P.A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., Marsden C.D. Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Neurosci. Lett. 206:1996;37-40.
16. McNaught K.St.P., Carrupt P.A., Altmore C., Cellamare S., Carotti A., Testa B., Jenner P., Marsden C.D. Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56:1998;921-933.
17. Migheli R., Godani C., Bciola L., Delodu M.R., Serra P.A., Zangani D., Natale G.D., Miele E., Desole M.S. Enhancing effect of manganese on L-DOPA-induced apoptosis in PC12 cells: role of oxidative stress. J. Neurochem. 73:1999;1155-1163.
18. Mizuno Y., Ikebe S., Hattori N., Hattori Y., Mochizuki H., Tanaka M., Ozawa T. Role of mitochondrial in the etiology and pathogenesis of Parkinson's disease. Biochim. Biophys. Acta. 1271:1995;265-274.
19. Morikawa N., Naoi N., Maruyama W., Ohta S., Kotake Y., Kawai H., Niwa T., Dostert P., Mizuno Y. Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and electron transfer complexes. J. Neural Transm. 105:1998;677-688.
20. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods. 65:1983;55-63.
21. +) and the structurally related compounds in vitro and in vivo. Eur. Neurol. 26(Suppl. 1):1987;11-15.
22. Ohta S. Isoquinolines in Parkinson's disease. Storch A., Collins M.A. Neurotoxic Factors in Parkinson's Disease and Related Disorders. vol. 3:2002;33-42 Plenum Press, New York.
23. Przedborski S., Vila M. MPTP: a review of its mechanisms of neurotoxicity. Clin. Neurosci. Res. 1:2001;407-418.
24. Sandstrom P.A., Mannie M.D., Buttke T.H. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidant: oxidative stress as a mediator of apoptosis. J. Leukoc. Biol. 55:1994;221-226.
25. Schapira A.H.V., Cooper J.M., Dexer D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex deficiency in Parkinson's disease. J. Neurochem. 54:1990;823-827.
26. Seaton T.A., Cooper J.M., Schapira A.H.V. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res. 777:1997;110-118.
27. Stanek J., Manske R.H.F. Phthalide isoquinoline alkaloids. Manske R.H.F., Holmes H.L. The Alkaloids, Chemistry and Physiology. 1968;167-198 Academic Press, New York.
28. Tang W., Eisenbrand G. Corydalis, T., Bess, F., Yanhusuo, Y.H., Chou et, C.C. Hsu. Chinese Drugs of Plant Origin. 1992;377-393 Springer Verlag, Heidelberg.
29. Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Methyl-1,2,3,4- tetrahydroisoquinoline, decreased in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. J. Neurochem. 57:1991;1940-1943.
30. Walkinshaw G., Waters C.M. Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinsons disease. J. Clin. Invest. 95:1995;2458-2464.